Kyle Bramley

Kyle Bramley, MD, is an Associate Professor in the Department of Internal Medicine at Yale School of Medicine, where he serves as Director of Interventional Pulmonology within the Section of Pulmonary, Critical Care and Sleep Medicine. He is affiliated with Yale Cancer Center, the Winchester Center for Lung Disease, and the Robotic Bronchoscopy Program at Smilow Cancer Hospital.

Research Interests: Dr. Bramley specializes in interventional pulmonology, with clinical and research expertise in pleural disease, benign and malignant airway disorders, and advanced diagnostic techniques including electromagnetic navigation bronchoscopy, robotic bronchoscopy, and ultrasound-guided pleural procedures. His work focuses on improving diagnostic yield, procedural safety, and patient outcomes in complex pulmonary conditions.

Publication Trends: His recent publications reflect a strong emphasis on procedural innovation and competency in interventional pulmonology. Key themes include the safety and efficacy of pleural interventions, advancements in bronchoscopic biopsy techniques, and multimodal approaches to diagnosing and managing lung cancer and airway diseases.

Scientific Awards:

• ATS Resident Travel Award
• Yale/Johnson and Johnson Physician Scholars in International Health
• Harold A. Lyons, MD Award for Excellence in Clinical Medicine
• Endowed Honor Scholarship
• Joshua H. Weiner, MD International Health Fellowship Award

Advising and Grants: While specific advisees and grant funding are not detailed in the available text, Dr. Bramley actively mentors trainees through his leadership in the Interventional Pulmonology fellowship and clinical research collaborations at Yale. He has led multicenter studies and contributed to national guidelines in his field.

Labs and Teams: Dr. Bramley is a key member of the Center for Thoracic Cancers and leads the Interventional Pulmonology team at Yale. He collaborates extensively with thoracic surgeons, oncologists, and radiologists through the Robotic Bronchoscopy Program and the Yale Cancer Center, forming an interdisciplinary team focused on early lung cancer detection and minimally invasive interventions.